- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Human Insulin Drugs and Delivery Devices market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Human Insulin Drugs and Delivery Devicesmarket, defines the market attractiveness level of Human Insulin Drugs and Delivery Devices market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Human Insulin Drugs and Delivery Devices industry, describes the types of Human Insulin Drugs and Delivery Devices market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Insulin Drugs and Delivery Devices market and the development prospects and opportunities of Human Insulin Drugs and Delivery Devices industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Insulin Drugs and Delivery Devices market in Chapter 13.
By Player:
Exir
Ypsomed
Medtronic
Eli Lilly
Biocon
Becton Dickinson
Julphar
Insulet
Novo Nordisk
Sanofi Aventis
By Type:
Insulin Pumps
Insulin Pens
Insulin Syringes
Basal or Long Acting Insulins
Bolus or Fast-Acting Insulins
By End-User:
Hospital
Household
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Human Insulin Drugs and Delivery Devices Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Human Insulin Drugs and Delivery Devices Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Human Insulin Drugs and Delivery Devices Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Human Insulin Drugs and Delivery Devices Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Human Insulin Drugs and Delivery Devices Market Analysis and Outlook to 2022
-
7.1 Global Human Insulin Drugs and Delivery Devices Consumption (2017-2022)
-
7.2 United States Human Insulin Drugs and Delivery Devices Consumption (2017-2022)
-
7.3 Europe Human Insulin Drugs and Delivery Devices Consumption (2017-2022)
-
7.4 China Human Insulin Drugs and Delivery Devices Consumption (2017-2022)
-
7.5 Japan Human Insulin Drugs and Delivery Devices Consumption (2017-2022)
-
7.6 India Human Insulin Drugs and Delivery Devices Consumption (2017-2022)
-
7.7 South Korea Human Insulin Drugs and Delivery Devices Consumption (2017-2022)
8 Region and Country-wise Human Insulin Drugs and Delivery Devices Market Analysis and Outlook to 2028
-
8.1 Global Human Insulin Drugs and Delivery Devices Consumption Forecast (2022-2028)
-
8.2 United States Human Insulin Drugs and Delivery Devices Consumption Forecast (2022-2028)
-
8.3 Europe Human Insulin Drugs and Delivery Devices Consumption Forecast (2022-2028)
-
8.4 China Human Insulin Drugs and Delivery Devices Consumption Forecast (2022-2028)
-
8.5 Japan Human Insulin Drugs and Delivery Devices Consumption Forecast (2022-2028)
-
8.6 India Human Insulin Drugs and Delivery Devices Consumption Forecast (2022-2028)
-
8.7 South Korea Human Insulin Drugs and Delivery Devices Consumption Forecast (2022-2028)
9 Global Human Insulin Drugs and Delivery Devices Market Outlook by Types and Applications to 2022
-
9.1 Global Human Insulin Drugs and Delivery Devices Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Insulin Pumps Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Insulin Pens Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Insulin Syringes Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Basal or Long Acting Insulins Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Bolus or Fast-Acting Insulins Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Insulin Drugs and Delivery Devices Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Household Consumption and Growth Rate (2017-2022)
10 Global Human Insulin Drugs and Delivery Devices Market Outlook by Types and Applications to 2028
-
10.1 Global Human Insulin Drugs and Delivery Devices Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Insulin Pumps Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Insulin Pens Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Insulin Syringes Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Basal or Long Acting Insulins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Bolus or Fast-Acting Insulins Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Human Insulin Drugs and Delivery Devices Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Household Consumption Forecast and Growth Rate (2022-2028)
11 Global Human Insulin Drugs and Delivery Devices Import and Export Analysis (Top 5 Countries)
-
11.1 Global Human Insulin Drugs and Delivery Devices Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Human Insulin Drugs and Delivery Devices Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Human Insulin Drugs and Delivery Devices Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Human Insulin Drugs and Delivery Devices Market Competitive Analysis
-
14.1 Exir
-
14.1.1 Exir Company Details
-
14.1.2 Exir Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Exir Human Insulin Drugs and Delivery Devices Product and Service
-
14.2 Ypsomed
-
14.2.1 Ypsomed Company Details
-
14.2.2 Ypsomed Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Ypsomed Human Insulin Drugs and Delivery Devices Product and Service
-
14.3 Medtronic
-
14.3.1 Medtronic Company Details
-
14.3.2 Medtronic Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Medtronic Human Insulin Drugs and Delivery Devices Product and Service
-
14.4 Eli Lilly
-
14.4.1 Eli Lilly Company Details
-
14.4.2 Eli Lilly Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly Human Insulin Drugs and Delivery Devices Product and Service
-
14.5 Biocon
-
14.5.1 Biocon Company Details
-
14.5.2 Biocon Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biocon Human Insulin Drugs and Delivery Devices Product and Service
-
14.6 Becton Dickinson
-
14.6.1 Becton Dickinson Company Details
-
14.6.2 Becton Dickinson Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Becton Dickinson Human Insulin Drugs and Delivery Devices Product and Service
-
14.7 Julphar
-
14.7.1 Julphar Company Details
-
14.7.2 Julphar Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Julphar Human Insulin Drugs and Delivery Devices Product and Service
-
14.8 Insulet
-
14.8.1 Insulet Company Details
-
14.8.2 Insulet Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Insulet Human Insulin Drugs and Delivery Devices Product and Service
-
14.9 Novo Nordisk
-
14.9.1 Novo Nordisk Company Details
-
14.9.2 Novo Nordisk Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novo Nordisk Human Insulin Drugs and Delivery Devices Product and Service
-
14.10 Sanofi Aventis
-
14.10.1 Sanofi Aventis Company Details
-
14.10.2 Sanofi Aventis Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sanofi Aventis Human Insulin Drugs and Delivery Devices Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Human Insulin Drugs and Delivery Devices
-
Figure Human Insulin Drugs and Delivery Devices Picture
-
Table Global Human Insulin Drugs and Delivery Devices Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Insulin Drugs and Delivery Devices Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Insulin Drugs and Delivery Devices Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Human Insulin Drugs and Delivery Devices Consumption by Country (2017-2022)
-
Figure United States Human Insulin Drugs and Delivery Devices Consumption and Growth Rate (2017-2022)
-
Table Europe Human Insulin Drugs and Delivery Devices Consumption and Growth Rate (2017-2022)
-
Figure China Human Insulin Drugs and Delivery Devices Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Insulin Drugs and Delivery Devices Consumption and Growth Rate (2017-2022)
-
Figure India Human Insulin Drugs and Delivery Devices Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Insulin Drugs and Delivery Devices Consumption and Growth Rate (2017-2022)
-
Figure Global Human Insulin Drugs and Delivery Devices Consumption Forecast by Country (2022-2028)
-
Figure United States Human Insulin Drugs and Delivery Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Insulin Drugs and Delivery Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Human Insulin Drugs and Delivery Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Insulin Drugs and Delivery Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Insulin Drugs and Delivery Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Insulin Drugs and Delivery Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Pumps Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Pens Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Syringes Consumption and Growth Rate (2017-2022)
-
Figure Global Basal or Long Acting Insulins Consumption and Growth Rate (2017-2022)
-
Figure Global Bolus or Fast-Acting Insulins Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Household Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Pumps Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Pens Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Syringes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Basal or Long Acting Insulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bolus or Fast-Acting Insulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Household Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Human Insulin Drugs and Delivery Devices Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Human Insulin Drugs and Delivery Devices Export by Region (Top 5 Countries) (2017-2028)
-
Table Exir (Foundation Year, Company Profile and etc.)
-
Table Exir Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exir Human Insulin Drugs and Delivery Devices Product and Service
-
Table Ypsomed (Foundation Year, Company Profile and etc.)
-
Table Ypsomed Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ypsomed Human Insulin Drugs and Delivery Devices Product and Service
-
Table Medtronic (Foundation Year, Company Profile and etc.)
-
Table Medtronic Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtronic Human Insulin Drugs and Delivery Devices Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Human Insulin Drugs and Delivery Devices Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Human Insulin Drugs and Delivery Devices Product and Service
-
Table Becton Dickinson (Foundation Year, Company Profile and etc.)
-
Table Becton Dickinson Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton Dickinson Human Insulin Drugs and Delivery Devices Product and Service
-
Table Julphar (Foundation Year, Company Profile and etc.)
-
Table Julphar Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Julphar Human Insulin Drugs and Delivery Devices Product and Service
-
Table Insulet (Foundation Year, Company Profile and etc.)
-
Table Insulet Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Insulet Human Insulin Drugs and Delivery Devices Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Human Insulin Drugs and Delivery Devices Product and Service
-
Table Sanofi Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi Aventis Human Insulin Drugs and Delivery Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Aventis Human Insulin Drugs and Delivery Devices Product and Service
-

Chinese